PXD076315 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Repurposing the antiplatelet drug prasugrel for Parkinson’s disease: Evidence of neuroprotective effects and proteomic profiles |
| Description | Chronic neuroinflammation is a hallmark pathological feature of Parkinson’s disease (PD) that contributes to progressive neuronal death. Current medications are largely palliative, underscoring the need for alternative therapeutic strategies. Drug repurposing offers a cost-effective and time-efficient approach by leveraging established safety profiles. Here, we screened the U.S. Food and Drug Administration–approved drug library using two in vitro PD models: 1-methyl-4-phenylpyridinium (MPP+)-induced primary cortical neurons and lipopolysaccharide (LPS)-induced BV2 microglial cells. Proteomic alterations following prasugrel treatment were profiled using Ingenuity Pathway Analysis. Neuroprotective effects were validated by biochemical assays and further confirmed in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model. We found that prasugrel, an antiplatelet drug used for acute coronary syndrome, exhibited significant neuroprotective and anti-inflammatory effects. It reduced the expression of apoptosis- and inflammation-related proteins, inhibited mitogen-activated protein kinase (MAPK)–mediated neuronal death and suppressed nuclear factor kappa B (NF-κB)-dependent inflammatory signaling. In vivo, prasugrel administration preserved dopaminergic neurons and improved motor performance in MPTP-treated mice. These findings demonstrate that prasugrel mitigates neuronal apoptosis and microglial activation through modulation of MAPK and NF-κB signaling pathways, supporting its development as a repurposed therapeutic candidate for PD. |
| HostingRepository | PRIDE |
| AnnounceDate | 2026-07-16 |
| AnnouncementXML | Submission_2026-07-15_17:59:19.560.xml |
| DigitalObjectIdentifier | https://doi.org/10.6019/PXD076315 |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Supported dataset by repository |
| PrimarySubmitter | Eunji Cho |
| SpeciesList | scientific name: Mus musculus (Mouse); NCBI TaxID: NEWT:10090; scientific name: Rattus norvegicus (Rat); NCBI TaxID: NEWT:10116; |
| ModificationList | acetylated residue; monohydroxylated residue |
| Instrument | Q Exactive HF |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2026-03-30 05:04:57 | ID requested | |
| ⏵ 1 | 2026-07-15 17:59:20 | announced | |
Publication List
Keyword List
| submitter keyword: Prasugrel, Drug repurposing, Proteomics,Parkinson’s disease |
Contact List
| Jong Hyuk Yoon |
| contact affiliation | Neurodegenerative Diseases Research Group, Korea Brain Research Institute |
| contact email | jhyoon@kbri.re.kr |
| lab head | |
| Eunji Cho |
| contact affiliation | Korea Brain Research Institute |
| contact email | prettybox5@gmail.com |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2026/07/PXD076315 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD076315
- Label: PRIDE project
- Name: Repurposing the antiplatelet drug prasugrel for Parkinson’s disease: Evidence of neuroprotective effects and proteomic profiles